Publications

1. Espina C, Ritchie D, Riboli E, Kromhout H, Franceschi S, Lansdorp-Vogelaar I, et al.; Working Groups of Scientific Experts (2026). European Code Against Cancer 5th edition: 14 ways you can help prevent cancer. Lancet Reg Health Eur. 63:101592. https://doi.org/10.1016/j.lanepe.2026.101592 PMID:41631169
2. Dolatkhah R, Onyije FM, Bouaoun L, Olsson A, Schüz J (2026). Early life environmental exposures and birth characteristics and childhood lymphoma risk: a systematic review and meta-analysis. J Natl Cancer Inst. 2026:djag136. https://doi.org/10.1093/jnci/djag136 PMID:42109041
3. Zupunski L, Yaumenenka A, Veyalkin I, Minenko V, Moiseyev P, Schüz J, et al. (2026). Lymphoma, multiple myeloma and leukaemia incidence in regions of Belarus most heavily contaminated by the Chernobyl accident. Int J Cancer. 158(12):3161–72. https://doi.org/10.1002/ijc.70346 PMID:41575069
4. Foerster M, Zins M, Goldberg M, Ribet C, Kab S, McCarty RD, et al. (2026). Tattoo practices and risk of hepatitis B and hepatitis C infection in the French Constances study. Int J Infect Dis. 163:108288. https://doi.org/10.1016/j.ijid.2025.108288 PMID:41386394
5. Feliu A, Barrera B, Boland V, Drury A, Hâncean MG, Geantă M, et al. (2026). Exploring individual and contextual determinants of cancer prevention behaviour change in the European Union: a qualitative study to inform implementation of the European Code Against Cancer. Lancet Reg Health Eur. 64:101633. https://doi.org/10.1016/j.lanepe.2026.101633 PMID:41816635
6. Mo T, Msoka EF, Narh CT, Mmbaga BT, Mitao M, Mshana GJ, et al. (2026). Breast cancer awareness and preferences for screening messaging on menstrual hygiene products in Ghana and Tanzania. Commun Med (Lond). 6(1):267. https://doi.org/10.1038/s43856-026-01522-9 PMID:41840175
7. Espina C, Ritchie D, Feliu A, Canelo-Aybar C, D’Souza E, Mitrou PN, et al. (2026). Developing evidence-based cancer prevention recommendations: methodology of the World Code Against Cancer Framework to create region-specific codes. Int J Cancer. 158(1):9–18. https://doi.org/10.1002/ijc.70068 PMID:40741905
8. Schüz J, Soerjomataram I, Foerster M, Langselius O, Rohrmann S, Vineis P, et al. (2025). Climate change mitigation and synergies with primary cancer prevention in Europe: time to implement opportunities. J Natl Cancer Inst. 117(12):2432–40. https://doi.org/10.1093/jnci/djaf182 PMID:40668754
9. Rodet N, Zahed H, Colombet M, Bray F, McCormack V (2025). Understanding age and sex differentials in cancer incidence and mortality: an international population-based study. Int J Cancer. 158(8):2102–10. https://doi.org/10.1002/ijc.70244 PMID:41208540
10. Olsson A, Schüz J, Bukhtiyarov I, Moissonnier M, Ostroumova E, Ferro G, et al. (2025). Cause-specific mortality among workers in asbestos mining and enrichment factories (Asbest Chrysotile Cohort Study) compared with the general population of Sverdlovsk Oblast, Russian Federation. J Occup Med Toxicol. 20(1):37. https://doi.org/10.1186/s12995-025-00484-3 PMID:41199374
11. Drozdovitch V, Lipikhina A, Apsalikov K, Brait Y, Tokanov A, Yessilkanov G, et al. (2025). Thyroid doses estimated for a cohort of people exposed to fallout from atmospheric nuclear weapons testing at the Semipalatinsk nuclear test site, Kazakhstan. Radiat Environ Biophys. 65(1):283–305. https://doi.org/10.1007/s00411-025-01155-x PMID:41247536
12. Mo T, Joffe M, Cubasch H, Galukande M, Parham G, Pinder L, et al. (2025). Breast cancer overall survival, annual risks of death, and survival gap apportionment in sub-Saharan Africa (ABC-DO): 7-year follow-up of a prospective cohort study. Lancet Glob Health. 13(10):e1681–90. https://doi.org/10.1016/S2214-109X(25)00273-6 PMID:40975077
13. Mo T, Zins M, Goldberg M, Ribet C, Kab S, Schreiver I, et al. (2025). Tattoos and risk of cutaneous melanoma and non-melanoma skin cancer in France. J Natl Cancer Inst. 118(3):476–84. https://doi.org/10.1093/jnci/djaf332 PMID:41259064
14. Kim J, Harper A, McCormack V, Sung H, Houssami N, Morgan E, et al. (2025). Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nat Med. 31(4):1154–62. https://doi.org/10.1038/s41591-025-03502-3 PMID:39994475
15. Boucheron P, Zietsman A, Anele A, Offiah AU, Galukande M, Parham G, et al. (2025). Measuring the WHO Global Breast Cancer Initiative Pillars’ key performance indicators in Sub-Saharan Africa: experience in the African Breast Cancer-Disparities in Outcomes hospital-based cohort study. EClinicalMedicine. 81:103104. https://doi.org/10.1016/j.eclinm.2025.103104 PMID:40034567
16. Olsson A, Bouaoun L, Schüz J, Vermeulen R, Behrens T, Ge C, et al. (2024). Lung cancer risks associated with occupational exposure to pairs of five lung carcinogens: results from a pooled analysis of case-control studies (SYNERGY). Environ Health Perspect. 132(1):17005. https://doi.org/10.1289/EHP13380 PMID:38236172
17. Schüz J, Kovalevskiy E, Olsson A, Moissonnier M, Ostroumova E, Ferro G, et al. (2024). Cancer mortality in chrysotile miners and millers, Russian Federation: main results (Asbest Chrysotile Cohort-Study). J Natl Cancer Inst. 116(6):866–75. https://doi.org/10.1093/jnci/djad262 PMID:38247448
18. Maroui MA, Odongo GA, Mundo L, Manara F, Mure F, Fusil F, et al. (2024). Aflatoxin B1 and Epstein-Barr virus-induced CCL22 expression stimulates B cell infection. Proc Natl Acad Sci U S A. 121(16):e2314426121. https://doi.org/10.1073/pnas.2314426121 PMID:38574017
19. Ghantous A, Nusslé SG, Nassar FJ, Spitz N, Novoloaca A, Krali O, et al. (2024). Epigenome-wide analysis across the development span of pediatric acute lymphoblastic leukemia: backtracking to birth. Mol Cancer. 23(1):238. https://doi.org/10.1186/s12943-024-02118-4 PMID:39443995
20. Bouaoun L, Byrnes G, Lagorio S, Feychting M, Abou-Bakre A, Béranger R, et al. (2024). Effects of recall and selection biases on modeling cancer risk from mobile phone use: results from a case-control simulation study. Epidemiology. 35(4):437–46. https://doi.org/10.1097/EDE.0000000000001749 PMID:38771708
    Winner of the prestigious Rothman Prize in 2025.
    Read more